Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

TR-516: 2-Methylimidazole (693-98-1)

Study Results

Chronic Bioassay Level of Evidence

An overview of chronic evidence from Rats studies.
Rats
View
  • Clear Evidence, Female, Rats
  • Some Evidence, Male, Rats
An overview of chronic evidence from Mice studies.
Mice
View
  • Some Evidence, Female, Mice
  • Some Evidence, Male, Mice

Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Mice study conclusions related to TR-516: 2-Methylimidazole (693-98-1).
Micronucleus - Mice
View
  • Male: Negative
View
  • Male: Positive
    Female: Positive
An overview of Genetic Toxicology Micronucleus Rats study conclusions related to TR-516: 2-Methylimidazole (693-98-1).
Micronucleus - Rats
View
  • Male: Negative
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to TR-516: 2-Methylimidazole (693-98-1).
Bacterial Mutagenicity
View
  • Negative

Citation Information

NTP. TR-516: 2-Methylimidazole (693-98-1). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Related Links

Publications

TR-516 Toxicology and Carcinogenesis Studies of 2-Methylimidazole (CASRN 693-98-1) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Study Data

Protocol

Toxicity and Carcinogenicity Studies

Evaluation of the Chronic Toxicity and Carcinogenicity (C92012B) of 2-Methylimidazole (693-98-1) in F344/N Rats Exposed via Dosed Feed
Pathology Tables
Individual Animal Data
Evaluation of the Chronic Toxicity and Carcinogenicity (C92012B) of 2-Methylimidazole (693-98-1) in B6C3F1 Mice Exposed via Dosed Feed
Pathology Tables
Individual Animal Data
Protocol

Genetic Toxicology Studies

Genetic Toxicity Evaluation of 2-Methylimidazole (693-98-1) in Micronucleus Study A05124 in B6C3F1 Mice
Summary and Individual Animal Data
Genetic Toxicity Evaluation of 2-Methylimidazole (693-98-1) in Micronucleus Study A69851 in B6C3F1 Mice
Summary and Individual Animal Data
Genetic Toxicity Evaluation of 2-Methylimidazole (693-98-1) in Micronucleus Study A84932 in F344 Rats
Summary and Individual Animal Data
Genetic Toxicity Evaluation of 2-Methylimidazole in Salmonella/E.coli Mutagenicity Test or Ames Test. Study A28742
Summary Data